Panel proposes framework for FDA to evaluate drug risks

被引：0

|

作者：

Stokes, Trevor

机构：

来源：

NATURE MEDICINE | 2012年 / 18卷 / 06期

关键词：

D O I：

10.1038/nm0612-839b

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：839 / 839

页数：1

相关论文

共 50 条

[1] Panel proposes framework for FDA to evaluate drug risks
Trevor Stokes
Nature Medicine, 2012, 18 : 839 - 839
[2] FDA proposes changes to ensure drug safety
Wechsler, Jill
FORMULARY, 2007, 42 (03) : 205 - 206
[3] The FDA Proposes Revisions to Pregnancy Information in Drug Labeling
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2008, 108 (11) : 32 - 34
[4] FDA IDENTIFIES CAUSES OF DRUG SHORTAGES, PROPOSES SOLUTIONS
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2019, 255 (12): : 1315 - 1315
[5] FDA creates panel on drug safety
Hanson, D
CHEMICAL & ENGINEERING NEWS, 2005, 83 (08) : 10 - 10
[6] FDA panel seeks to balance risks in warnings for antidepressants
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (06): : 573 - 574
[7] FDA PROPOSES TO PROHIBIT 415 INGREDIENTS FROM OTC DRUG PRODUCTS
NIGHTINGALE, SL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (14): : 1828 - 1828
[8] FDA proposes changes in drug information regulation to prevent congressional action
Wechsler, J
FORMULARY, 1996, 31 (07) : 623 - 624
[9] ALS DRUG SQUEAKS THROUGH FDA PANEL
BARNETT, AA
LANCET, 1995, 346 (8979): : 897 - 897
[10] NICOTINE IS ADDICTIVE DRUG, SAYS FDA PANEL
EMBER, L
CHEMICAL & ENGINEERING NEWS, 1994, 72 (32) : 9 - 9

← 1 2 3 4 5 →